Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.
about
Liver transplantation for hepatocellular carcinoma beyond the Milan criteriaUsefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsReduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatmentBarcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortPrognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection.Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.Reassessing hepatocellular carcinoma staging in a changing patient population.Staging of biliary tract and primary liver tumors.Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.Incorporation of extranodal metastasis of gastric carcinoma into the 7th edition UICC TNM staging systemPrognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era.The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.A New Subclassification of pT4 Gastric Cancers According to the Width of Serosal Invasion.Treatment of non-resectable hepatocellular carcinoma.Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinomaProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell CarcinomaA novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.Staging classifications for hepatocellular carcinoma.Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma.Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systemsLiver resection in the treatment of hepatocellular carcinoma.Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodesComparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experienceA microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.Review of current staging systems for hepatocellular carcinoma.Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.
P2860
Q24658550-3CD377B3-2D00-4B37-B135-790EA60080F9Q26743666-B4818CD9-57F1-4DF3-BBDB-4FDB4DC178D3Q28487832-F3E1F0F0-45B8-4223-B509-90FC8875E11EQ33572657-14C1D4FE-E9BA-4246-9656-58F4D6B2384FQ33584097-7EB3838B-053A-465D-A660-E8529CBEC9AAQ33652003-C18A6F9D-28CC-47FA-8B9D-D9DB23C7DE59Q33767286-3A69EF92-D32A-468A-922A-A35244B2D585Q33773415-3AC845F2-F9FB-4834-BECD-C1B827642EC9Q33787850-5B52A5B5-42F9-40AB-939F-A63BAF1A7540Q33939538-7D978D1B-C54F-4ECF-9D8C-AD548FB1159DQ34061430-549051FF-2603-4B4B-AE39-16E5BB5EADFCQ34494749-C1E4C94D-247B-40CD-A3F1-C8408FDEFEABQ34572243-4449A878-2DF6-418C-89F5-8E990C2A6666Q34641400-0758D8A4-CEE7-4D47-A7D3-2BB8CED560E9Q34733478-057AC660-51E1-479C-AA76-74687CC546DDQ34797722-A8849969-1EA4-4332-97B9-C574EE0B6ADCQ35020886-AB7AEB21-FE5B-43F3-9FAF-3C14733109E9Q35109504-053EE305-8619-478C-B166-7D0AD8D6CFACQ35113002-D4D8DFF0-BCCB-4F7F-9EF1-55EC0AAE375CQ35208826-5A84D8EE-1395-4766-B7B6-D7DC8D931DD0Q35435112-7C43962F-3FC4-41B6-9187-D9215A1F8112Q35597216-4BE1F496-5CF6-4F2C-A68F-8F9AFC508005Q35597241-8DC814EE-7A19-4BFF-8853-E6F558BAB446Q35606833-05B3062F-8B0B-4C51-9FBE-2BA4AC627210Q35858185-DDCC543B-B5C4-4CCA-B37A-F04DE0186940Q35889913-2F2F432C-7A2A-4F4A-9BCB-888C33510072Q36075141-056479FE-CDDA-4C7D-9E6A-3866069767FBQ36150362-4B8B40C1-9662-46BA-965A-83D6B8BCBD78Q36217074-3A1A6F48-E119-4036-A68E-B1387D44EEEDQ36316052-1387A030-4D1A-4E27-AA63-F452261653D4Q36439327-8640E07B-301C-4615-85B7-212DAB4610A9Q36448689-EE801021-DCA1-42FF-ADED-088059258D44Q36546836-334FD8AD-686C-4070-9B53-DA1C4079A14AQ36741673-E2585405-8676-4187-939D-C0A3E4799D72Q36772208-1643CF3B-CB0B-4DB8-9C5E-31D6C0BEECE0Q36816413-E6068B8C-93F0-4E22-B05A-AE15E9B448E7Q36945069-56D3E6A7-7F1F-4F0E-809A-618208604770Q37190524-A13D66CA-72DA-4EB5-B39F-D6A96C88BF71Q37241565-DCCE4CAA-A8B2-443B-B18D-A90526545122Q37263149-D4979F99-6848-47C0-9AAB-2E841C0803CE
P2860
Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Discrimination value of the ne ...... of the Liver Italian Program.
@en
Discrimination value of the new western prognostic system
@nl
type
label
Discrimination value of the ne ...... of the Liver Italian Program.
@en
Discrimination value of the new western prognostic system
@nl
prefLabel
Discrimination value of the ne ...... of the Liver Italian Program.
@en
Discrimination value of the new western prognostic system
@nl
P2093
P356
P1433
P1476
Discrimination value of the ne ...... of the Liver Italian Program.
@en
P2093
Fukukura Y
Hokotate H
P304
P356
10.1053/JHEP.2001.27219
P407
P577
2001-09-01T00:00:00Z